Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lerer

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysisYoav Kohn, Eduardo Danilovich, Dvorah Filon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 5, 2006
Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factorsAvi Yakir, Amihai Rigbi, Kyra Kanyas, et al.
Biological Psychiatry|January 4, 2011
Association of reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli populationLior Greenbaum, Raz Levin, Elad Lerer, et al.
Psychiatry Research|February 19, 2003
Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analysesOmer Bonne, Yoram Louzoun, Itzhak Aharon, et al.
The International Journal of Neuropsychopharmacology|May 6, 2006
Brain SPECT study of common ground between hypothyroidism and depressionYodphat Krausz, Nanette Freedman, Hava Lester, et al.
Frontiers in Neuroscience|April 19, 2013
Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's diseaseLior Greenbaum, Mordechai Lorberboym, Eldad Melamed, et al.
Frontiers in Pharmacology|May 3, 2024
Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulatorsElad Lerer, Alexander Botvinnik, Orr Shahar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2020
Placebo-To be or not to be? Are there really alternatives to placebo-controlled trials?Fas Jacob Krol, Michal Hagin, Eduard Vieta, et al.
Parkinsonism & Related Disorders|August 14, 2012
Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interactionLior Greenbaum, Amihai Rigbi, Nurit Lipshtat, et al.
Psychiatry Research|November 13, 2008
Correlates of response to Olanzapine in a North Indian Schizophrenia samplePramod Thomas, Vibhuti Srivastava, Anuradha Singh, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysisYoav Kohn, Eduardo Danilovich, Dvorah Filon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 5, 2006
Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factorsAvi Yakir, Amihai Rigbi, Kyra Kanyas, et al.
Biological Psychiatry|January 4, 2011
Association of reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli populationLior Greenbaum, Raz Levin, Elad Lerer, et al.
Psychiatry Research|February 19, 2003
Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analysesOmer Bonne, Yoram Louzoun, Itzhak Aharon, et al.
The International Journal of Neuropsychopharmacology|May 6, 2006
Brain SPECT study of common ground between hypothyroidism and depressionYodphat Krausz, Nanette Freedman, Hava Lester, et al.
Frontiers in Neuroscience|April 19, 2013
Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's diseaseLior Greenbaum, Mordechai Lorberboym, Eldad Melamed, et al.
Frontiers in Pharmacology|May 3, 2024
Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulatorsElad Lerer, Alexander Botvinnik, Orr Shahar, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2020
Placebo-To be or not to be? Are there really alternatives to placebo-controlled trials?Fas Jacob Krol, Michal Hagin, Eduard Vieta, et al.
Parkinsonism & Related Disorders|August 14, 2012
Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interactionLior Greenbaum, Amihai Rigbi, Nurit Lipshtat, et al.
Psychiatry Research|November 13, 2008
Correlates of response to Olanzapine in a North Indian Schizophrenia samplePramod Thomas, Vibhuti Srivastava, Anuradha Singh, et al.
Pageof 15